![]() Highlight Therapeutics Highlight Therapeutics (formerly Bioncotech) is a clinical-stage immune-oncology company. | ![]() Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics. | ![]() Biomea Fusion Biomea Fusion is a biopharmaceutical company focused on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers. | CytoMed Therapeutics CytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers. | ![]() Nexomics Biosciences Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community. | |
Founding Date | Founding Date 2010 | Founding Date 1980 | Founding Date 2017 | Founding Date 2018 | Founding Date 2007 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Paterna, Valencia, ES HQ | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more | Locations Redwood City, US HQ | Locations Singapore, SG HQ Masai, MY | Locations Rocky Hill, US HQ Mansfield, US |
Employees | Employees 16 | Employees 25,200 | Employees 1240% decrease | Employees 24 | Employees 1220% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 170.4 b | Valuation ($) 449.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income $7.7b (FY, 2025) | Net income ($61.8m) (FY, 2025) | Net income N/A | Net income N/A |

Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.
View company
Biomea Fusion is a biopharmaceutical company focused on the discovery, development, and commercialization of irreversible small molecules to treat patients with genetically defined cancers.
View companyCytoMed Therapeutics is a company that focuses on translating its technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based immunotherapeutics for the treatment of cancers.
View company
Nexomics Biosciences is a contract research organization offering gene-to‑structure services to the biopharmaceutical community.
View company